跳至主要内容
临床试验/ISRCTN52148405
ISRCTN52148405已完成Unknown

Oral dydrogesterone associated with vaginal micronized progesterone supplementation vs vaginal micronized progesterone alone supplementation for luteal phase support in in vitro fertilization patients: effects on pregnancy and live birth rates

One Day Medical Center srl0 个研究点目标入组 620 人开始时间: 2023年8月15日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
620

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Infertility attributable to tubal factors, moderate endometriosis, male factor, or idiopathic infertility
  • 2. Serum hormonal profile within the normal range (AMH >1 ng/ml)
  • 3. Regular menstrual cycles
  • 4. The presence of a normal uterine cavity
  • 5. Body mass index (BMI) of 20–26 kg/m²

排除标准

  • 1. Infertility attributable to genetic factors or severely reduced ovarian reserve
  • 2. Serum hormonal profile showing a reduced ovarian reserve (AMH <0.9 ng/ml)
  • 3. Irregular menstrual cycles or amenorrhea
  • 4. Congenital or acquired uterine malformation
  • 5. A body mass index (BMI) <20 or >26 kg/m²

研究者

发起方
One Day Medical Center srl

相似试验